CRIS
Overvalued by 126.4% based on the discounted cash flow analysis.
Market cap | $89.71 Million |
---|---|
Enterprise Value | $33.37 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-8.96 |
Beta | 0.25 |
Outstanding Shares | 5,894,085 |
Avg 30 Day Volume | 42,935 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -1.89 |
---|---|
PEG | -55.97 |
Price to Sales | 14.52 |
Price to Book Ratio | 4.84 |
Enterprise Value to Revenue | 3.33 |
Enterprise Value to EBIT | -0.69 |
Enterprise Value to Net Income | -1 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data